Skip to main content
Equibles

Woodline Partners LP

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1784547 San Francisco, CA
Back to MDGL Full portfolio

Position in MDGL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$67,601,468
+$1,697,119 QoQ
Shares Held
125,899
0.0% QoQ
Ownership
0.545%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. MDGL ranks #17 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in MDGL

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67,601,468 125,899
2026-03-31 $65,904,349 125,899
2025-12-31 $73,176,262 125,659
2025-09-30 $47,630,465 103,847
2025-06-30 $48,308,304 159,623
2025-03-31 $105,143,332 317,433
2024-12-31 $95,384,232 309,117
2024-09-30 $31,215,439 147,090
2024-06-30 $38,748,649 138,309
2024-03-31 $5,260,688 19,700
2023-03-31 $2,993,849 12,358
2022-12-31 $458,304 1,579
2022-09-30 $1,177,813 18,123
2022-06-30 $5,882,158 82,176